Maria T. Borrello

Sunderland, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Pharmacological manipulation of liver fibrosis progression using novel HDAC6 inhibitors.

Pharmacological manipulation of liver fibrosis progression using novel HDAC6 inhibitors.

Journal: The FEBS journal

Published: July 19, 2024

Traditional Knowledge Evolution over Half of a Century: Local Herbal Resources and Their Changes in the Upper Susa Valley of Northwest Italy.

Traditional Knowledge Evolution over Half of a Century: Local Herbal Resources and Their Changes in the Upper Susa Valley of Northwest Italy.

Journal: Plants (Basel, Switzerland)

Published: November 27, 2023

Chronic liver diseases: From development to novel pharmacological therapies: IUPHAR Review 37.

Chronic liver diseases: From development to novel pharmacological therapies: IUPHAR Review 37.

Journal: British journal of pharmacology

Published: November 23, 2021

The unfolded protein response: An emerging therapeutic target for pancreatitis and pancreatic ductal adenocarcinoma.

The unfolded protein response: An emerging therapeutic target for pancreatitis and pancreatic ductal adenocarcinoma.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: September 08, 2021

NUPR1 interacts with eIF2α and is required for resolution of the ER stress response in pancreatic tissue.

NUPR1 interacts with eIF2α and is required for resolution of the ER stress response in pancreatic tissue.

Journal: The FEBS journal

Published: May 22, 2020

Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib.

Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 02, 2020

Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer.

Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer.

Journal: Oncogene

Published: December 04, 2019

Pharmacological inhibition of lysine-specific demethylase 1 (LSD1) induces global transcriptional deregulation and ultrastructural alterations that impair viability in Schistosoma mansoni.

Pharmacological inhibition of lysine-specific demethylase 1 (LSD1) induces global transcriptional deregulation and ultrastructural alterations that impair viability in Schistosoma mansoni.

Journal: PLoS neglected tropical diseases

Published: November 08, 2019

Isoform-selective HDAC1/6/8 inhibitors with an imidazo-ketopiperazine cap containing stereochemical diversity.

Isoform-selective HDAC1/6/8 inhibitors with an imidazo-ketopiperazine cap containing stereochemical diversity.

Journal: Philosophical transactions of the Royal Society of London. Series B, Biological sciences

Published: March 08, 2018

LSD1 inhibition attenuates androgen receptor V7 splice variant activation in castration resistant prostate cancer models.

LSD1 inhibition attenuates androgen receptor V7 splice variant activation in castration resistant prostate cancer models.

Journal: Cancer cell international

Published: February 26, 2018

Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A).

Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A).

Journal: Bioorganic & medicinal chemistry letters

Published: February 22, 2017

cis-Cyclopropylamines as mechanism-based inhibitors of monoamine oxidases.

cis-Cyclopropylamines as mechanism-based inhibitors of monoamine oxidases.

Journal: The FEBS journal

Published: October 28, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026